Interaction médicamenteuse entre Sutent® (sunitinib) et Bi-spirogyl® (spiramycine-métronidazole) : risque de toxicité: Drug Interaction between Sutent® (sunitinib) and Bi-spirogyl® (spiramycin-metronidazol) : Risk of Toxicity

Therapie. 2008 Nov-Dec;63(6):475-6. doi: 10.2515/therapie/2008068.

[Article in French]

¹ Centre National de Pharmacovigilance, Tunis, Tunisie.
² Centre National de Pharmacovigilance, Tunis, Tunisie. Electronic address: [email protected].

No abstract available

Keywords: drug interaction; interaction médicamenteuse; spiramycin; spiramycine; sunitinib.